Plasma homocysteine as a risk factor for dementia and Alzheimer's disease
- PMID: 11844848
- DOI: 10.1056/NEJMoa011613
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease
Abstract
Background: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies.
Methods: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6.
Results: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled.
Conclusions: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Comment in
-
Homocysteine and dementias.N Engl J Med. 2002 Feb 14;346(7):466-8. doi: 10.1056/NEJM200202143460702. N Engl J Med. 2002. PMID: 11844846 No abstract available.
-
Elevated homocysteine: a new marker for dementia?CMAJ. 2002 Apr 16;166(8):1068. CMAJ. 2002. PMID: 12030205 Free PMC article. No abstract available.
-
Homocysteine and dementia.N Engl J Med. 2002 Jun 20;346(25):2007; author reply 2008. doi: 10.1056/NEJM200206203462514. N Engl J Med. 2002. PMID: 12075065 No abstract available.
-
Homocysteine and dementia.N Engl J Med. 2002 Jun 20;346(25):2007; author reply 2008. N Engl J Med. 2002. PMID: 12078704 No abstract available.
-
Elevated plasma total homocysteine levels increased the risk for dementia in the elderly.ACP J Club. 2002 Sep-Oct;137(2):76. ACP J Club. 2002. PMID: 12207454 No abstract available.
-
Elevated plasma total homocysteine increased the risk of dementia in the elderly.Evid Based Ment Health. 2002 Nov;5(4):126. doi: 10.1136/ebmh.5.4.126. Evid Based Ment Health. 2002. PMID: 12440468 No abstract available.
Similar articles
-
Homocysteine and folate as risk factors for dementia and Alzheimer disease.Am J Clin Nutr. 2005 Sep;82(3):636-43. doi: 10.1093/ajcn.82.3.636. Am J Clin Nutr. 2005. PMID: 16155278
-
Homocysteine levels and the risk of osteoporotic fracture.N Engl J Med. 2004 May 13;350(20):2033-41. doi: 10.1056/NEJMoa032546. N Engl J Med. 2004. PMID: 15141041
-
The methionine-homocysteine cycle and its effects on cognitive diseases.Altern Med Rev. 2003 Feb;8(1):7-19. Altern Med Rev. 2003. PMID: 12611557 Review.
-
Hypohomocysteinemia may increases the risk of dementia and Alzheimer's disease: A nationwide population-based prospective cohort study.Clin Nutr. 2021 Jul;40(7):4579-4584. doi: 10.1016/j.clnu.2021.05.034. Epub 2021 Jun 9. Clin Nutr. 2021. PMID: 34229262
-
The worldwide challenge of the dementias: a role for B vitamins and homocysteine?Food Nutr Bull. 2008 Jun;29(2 Suppl):S143-72. doi: 10.1177/15648265080292S119. Food Nutr Bull. 2008. PMID: 18709889 Review.
Cited by
-
Elevated homocysteine levels are associated with low muscle strength and functional limitations in older persons.J Nutr Health Aging. 2013;17(6):578-84. doi: 10.1007/s12603-013-0047-2. J Nutr Health Aging. 2013. PMID: 23732556
-
Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease.Alzheimers Dement (Amst). 2015 Sep 21;1(4):464-71. doi: 10.1016/j.dadm.2015.08.001. eCollection 2015 Dec. Alzheimers Dement (Amst). 2015. PMID: 27239525 Free PMC article.
-
Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons.J Cereb Blood Flow Metab. 2016 Jan;36(1):132-42. doi: 10.1038/jcbfm.2015.121. J Cereb Blood Flow Metab. 2016. PMID: 26036933 Free PMC article. Review.
-
Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.Aging Dis. 2015 Aug 1;6(4):282-99. doi: 10.14336/AD.2014.002. eCollection 2015 Aug. Aging Dis. 2015. PMID: 26236550 Free PMC article. Review.
-
Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia.JAMA Psychiatry. 2013 May;70(5):481-9. doi: 10.1001/jamapsychiatry.2013.900. JAMA Psychiatry. 2013. PMID: 23467813 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases